Federal Trade Commission v. Lifewatch Inc.

176 F. Supp. 3d 757, 2016 U.S. Dist. LEXIS 45057, 2016 WL 1315063
CourtDistrict Court, N.D. Illinois
DecidedMarch 31, 2016
Docket15 C 5781
StatusPublished
Cited by11 cases

This text of 176 F. Supp. 3d 757 (Federal Trade Commission v. Lifewatch Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Federal Trade Commission v. Lifewatch Inc., 176 F. Supp. 3d 757, 2016 U.S. Dist. LEXIS 45057, 2016 WL 1315063 (N.D. Ill. 2016).

Opinion

Memorandum Opinion and Order

Gary Feinerman, United States District Judge

The Federal Trade Commission (“FTC” or “Commission”) and the Attorney General of Florida brought this suit against Life-watch Inc. and its chief executive officer, Evan Sirlin, alleging violations of the Federal Trade Commission Act (“FTC Act”), 15 U.S.C. § 41 et seq., the Telemarketing Sales Rule (“TSR”),. 16 C.F.R. Part 310, and the Florida Deceptive and Unfair Trade Practices Act (“FDUTPA”), Fla. Stat. § 501.201 et seq., which prohibit the making of material misrepresentations to consumers and engaging in deceptive and abusive telemarketing practices. Doc. 1. Plaintiffs moved for a preliminary injunction, Doc. 9, and the court allowed the parties to conduct discovery, Doc. 83. A hearing was held, .Doc. 114; Defendants have moved to strike certain of Plaintiffs’ exhibits, Docs. Ill, 117; and the parties filed summation briefs, Docs. 122, 124. For the following reasons, Defendants’ motions to strike are denied in part and denied as moot in part, and Plaintiffs’ motion for a preliminary injunction is granted.

Preliminary Factual Findings

Lifewatch is a company based in Lyn-brook, New York, that provides personal medical alert monitoring systems and services to elderly and disabled customers. Doc. 15-1 at 8; Doc. 87-1 at ¶2. The medical alert devices (typically a small pendant worn as a necklace or wristband) enable users to call emergency response services by simply pressing a button. Doc. 10 at 10-11; Doc. 87-1 at ¶ 4. Sirlin is Lifewatch’s chief executive officer.- Doc. 87-1 at ¶ 1. Over the last three years, Lifewatch has maintained business relationships with approximately 60,000 customers. Id. at ¶3. Lifewatch does not have its own sales personnel or marketing department; instead, it conducts sales through telemarketing companies. Id. at ¶¶ 8-9.

Plaintiffs allege that the telemarketing companies have violated several laws in selling Lifewatch’s medical alert devices and that Defendants are hable for those violations. Plaintiffs claim that the telemarketers make misrepresentations by telling consumers that: (1) they will receive a free medical alert device, only to later learn that they must pay a monthly service fee and return the device if they discontinue service, Doc. 10 at 17-18; (2) a friend, family member, or doctor purchased the device for them or referred them for a special offer, Id. at 18; (3) the device has been recommended by the American Diabetes Association, the Ameri[761]*761can Heart Association, the American Red Cross, the National Institute on Aging, and/or the American Association of Retired Persons, Id. at 18-19; (4) they will not be charged until they receive the device and activate it, Id. at 20-21; and (5) if they are not satisfied with the device, Life-watch will cover the cost of return shipping, Id. at 23-24. Plaintiffs further allege that the telemarketers have engaged in illegal telemarketing practices by contacting individuals on the National Do Not Call (“DNC”) Registry; using prerecorded messages when making outbound calls to potential customers (a practice known as “robocalling”); and transmitting phony caller identification information to mask the origins of the call (a practice known as “spoofing”). Doc. 10 at 11-13.

Defendants object to the reliability of Plaintiffs’ evidence and assert that much of the alleged misconduct cannot be linked to Lifewateh. Defendants raise two principal defenses.

First, Defendants argue that they are not legally responsible for the telemarketers’ conduct. According to Defendants, the telemarketers exist and operate wholly independently of Lifewateh and “develop and design their own marketing strategies.” Doc. 87 at 14. Defendants add that the telemarketers sell medical alert devices on a generic basis and then, in turn, sell those customer accounts to medical alert companies like Lifewateh for fulfillment. Id.. at 11. Defendants further assert that Lifewateh purchases those accounts on a non-exclusive basis — meaning that any medical alert company could theoretically fulfill those contracts. Ibid.

Plaintiffs paint a darker picture. They believe that Lifewateh intends for its telemarketers to employ illegal tactics or, at a minimum, turns a blind eye to them. In Plaintiffs’ view, Lifewateh “has structured its relationships with telemarketers in such a way as to insulate itself from liability.” Doc. 10 at 25. According to Plaintiffs, this is evidenced by the fact that “Defendants have employed a revolving door of outside telemarketers who have engaged in widespread abusive and deceptive sales tactics” and done little to rein them in. Doc. 94 at 7. Plaintiffs also submit that because Life-watch has a principal-agent relationship with its telemarketers, it cannot evade liability for their actions. Id. at 20-21. (While acknowledging Defendants’ position that the telemarketers are not their employees or agents, the court for ease of exposition will refer to them as “Life-watch’s telemarketers.”)

Second, Defendants contend that even if they are liable for the telemarketers’ past misconduct, Lifewatch’s new quality control program ensures that their current telemarketers are legally compliant. Doc. 87 at 30-31. According to Defendants, this makes a preliminary injunction no longer necessary or warranted. Ibid. Plaintiffs respond by saying that Life-watch’s self-policing measures are a farce instituted only in the face of law enforcement scrutiny. Doc. 94 at 22. Without an injunction, Plaintiffs fear that “Defendants could roll-back their current efforts” and revert to their bad habits once this litigation ends. Ibid.

Before proceeding, the court addresses two global issues raised in Defendants’ motions to strike. First, Defendants argue Plaintiffs rely on inadmissible hearsay. That argument is meritless. “The purpose of a preliminary injunction is merely to preserve the relative positions of the parties until a trial on the. merits can be held.” Univ. of Tex. v. Camenisch, 451 U.S. 390, 395, 101 S.Ct. 1830, 68 L.Ed.2d 175 (1981). Given its temporary nature, “a preliminary injunction is customarily granted on the basis of procedures that are less formal and evidence that is less complete than in a trial on the merits.” [762]*762Ibid, Settled law holds that these relaxed evidentiary standards permit a district court to consider hearsay at the preliminary injunction stage. See SEC v. Cherif, 933 F.2d 403, 412 n. 8 (7th Cir.1991) (“[Hjearsay can be considered in entering a, preliminary injunction.”); Mullins v. City of New York, 626 F.3d 47, 52 (2nd Cir.2010) (“hearsay evidence may be considered by a district court in determining whether to grant a preliminary injunction”); Levi Strauss & Co, v. Sunrise Int’l Trading Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
176 F. Supp. 3d 757, 2016 U.S. Dist. LEXIS 45057, 2016 WL 1315063, Counsel Stack Legal Research, https://law.counselstack.com/opinion/federal-trade-commission-v-lifewatch-inc-ilnd-2016.